RxSight, Inc. (RXST)
NASDAQ: RXST · IEX Real-Time Price · USD
59.63
+2.93 (5.17%)
At close: May 2, 2024, 4:00 PM
59.95
+0.32 (0.54%)
After-hours: May 2, 2024, 4:09 PM EDT
RxSight Revenue
In the year 2023, RxSight had annual revenue of $89.08M with 81.77% growth. Revenue in the quarter ending December 31, 2023 was $28.58M with 77.65% year-over-year growth.
Revenue (ttm)
$89.08M
Revenue Growth
+81.77%
P/S Ratio
24.56
Revenue / Employee
$238,174
Employees
374
Market Cap
2.22B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 89.08M | 40.07M | 81.77% |
Dec 31, 2022 | 49.01M | 26.41M | 116.90% |
Dec 31, 2021 | 22.59M | 7.92M | 53.92% |
Dec 31, 2020 | 14.68M | 12.44M | 554.98% |
Dec 31, 2019 | 2.24M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teladoc Health | 2.62B |
Privia Health Group | 1.66B |
Guardant Health | 563.95M |
STAAR Surgical Company | 322.42M |
Deciphera Pharmaceuticals | 163.36M |
Kymera Therapeutics | 78.59M |
Arvinas | 78.50M |
Intellia Therapeutics | 36.28M |
RXST News
- 10 days ago - RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 - GlobeNewsWire
- 4 weeks ago - RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting - GlobeNewsWire
- 5 weeks ago - RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference - GlobeNewsWire
- 2 months ago - RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 2 months ago - RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 - GlobeNewsWire
- 4 months ago - RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance - GlobeNewsWire
- 4 months ago - RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - GlobeNewsWire